Concepedia

Author

Nina Knutsson

University of Gothenburg

Also Known As

N Knutsson, NINA KNUTSSON, Nina Knutsson

10

Publications

258

Citations

9

H-Index

12

Concepts

All Affiliations

University of GothenburgSahlgrenska University HospitalNational Institutes of HealthStatens Serum InstitutBaxter (United States)
NK

About

Nina Knutsson is an author at University of Gothenburg specializing in medicine, vaccination, and vaccine development.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

92

2

Immunology

2

2

33

3

Allergy Medicine

1

1

22

4

Newborn Medicine

1

1

37

5

Drug Allergy

1

1

22

Nina Knutsson

×

7

Publications

216

Citations

7

H-Index

YearCitations

Mass Vaccination of Children with Pertussis Toxoid—Decreased Incidence in Both Vaccinated and Nonvaccinated Persons

J Taranger, Birger Trollfors, Elisabet Bergfors,

Clinical Infectious Diseases

2001

79

Vaccination of infants with a four-dose and a three-dose vaccination schedule

J Taranger, Birger Trollfors, Nina Knutsson,

Vaccine

1999

37

Antibody persistence in five-year-old children who received a pentavalent combination vaccine in infancy

Rose‐Marie Carlsson, Bo A. Claesson, EVA FAGERLUND,

The Pediatric Infectious Disease Journal

2002

32

Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose

Birger Trollfors, Nina Knutsson, J Taranger,

European Journal of Pediatrics

2005

22

Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccine

Nina Knutsson, Birger Trollfors, J Taranger,

Vaccine

2001

20

Immediate injection pain in infants aged 18 months during vaccination against measles, mumps and rubella with either Priorix® or MMR-II®

Nina Knutsson, Ulla-Britt Jansson, Bernt Alm

Vaccine

2006

13

ANTIBODIES AGAINST HAEMOPHILUS INFLUENZAE TYPE b CAPSULAR POLYSACCHARIDE AND TETANUS TOXOID BEFORE AND AFTER A BOOSTER DOSE OF THE CARRIER PROTEIN NINE YEARS AFTER PRIMARY VACCINATION WITH A PROTEIN CONJUGATE VACCINE

Bo A. Claesson, Birger Trollfors, Teresa Lagergård,

The Pediatric Infectious Disease Journal

2005

13

Page 1